Trial
NCT00880009
Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Pfizer
Collaborators
—
Condition
Breast Cancer
Intervention
Bosutinib
Why stopped
See termination reason in detailed description.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-27